Devices, systems, and methods for occluding anatomical channel
By applying coating material to the saddle area of the occlusion device and contacting the tissue with the retaining member, the problems of material flow and device migration are solved, and a stable occlusion effect between the duodenum and the stomach is achieved.
Patent Information
- Application Number
- CN202380031553.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-02-08
- Filing Date
- 2023-02-07
- Publication Date
- 2024-11-15
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The prior art is difficult to effectively prevent the flow of substances through the body channels while preventing the migration of implantable occlusion devices, especially in the pylorus between the duodenum and the stomach, where there is a problem that the device is moved or discharged.
A occlusion device is designed, including a saddle area, a first retaining member extending outward along a first end of the occlusion device and a second retaining member extending outward along a second end of the occlusion device, and the coating material is Applied on the saddle area to block or inhibit material flow and contact tissue through the first and second retaining members to promote tissue growth, enhancing the fixation of the device.
Effectively preventing the flow of substances through the lumen, and enhancing the fixation of the device through tissue growth, reducing the risk of migration of the device and improving the stability of deployment in the body.
Smart Images

Figure CN118973523A_ABST
Abstract
Description
Cross-reference to related applications
[0001] This application claims priority to U.S. Provisional Application No. 63 / 307,764, filed on February 8, 2022, the entire disclosure of which is hereby incorporated by reference into this document for all purposes. Technical Field
[0002] The present disclosure relates generally to the field of implantable devices, systems and methods. More specifically, the present disclosure relates to the field of implantable devices, systems and methods for occluding anatomical passages. Background Art
[0003] Various medical treatments involve blocking the flow of material through body passages. For example, treatments for various conditions such as obesity, diabetes, or duodenal ulcers involve bypassing the duodenum or restricting the flow of material through the duodenum. Common bariatric surgeries include sleeve gastrectomy, Roux-en-Y gastric bypass, and gastric banding, which are either obstructive (as in the case of gastric banding and sleeve gastrectomy) or malabsorptive, or both (as in the case of Roux-en-Y surgery). All of these procedures are highly invasive and have the potential for serious complications. Newer, less invasive procedures with less associated trauma and lower risk of complications involve the creation of an anastomosis, such as an anastomosis between the stomach and the jejunum (gastrojejunostomy, or GJ), and pyloric closure via an endoscopic procedure (e.g., endoscopic ultrasound procedure, or EUS (endoscopic ultrasound procedure)), such as the NOTES (natural orifice transluminal endoscopic surgery) procedure. If the treatment requires bypassing the duodenum entirely, occlusion (e.g., complete occlusion) of the pylorus may be required. An occluding device, such as a duodenal exclusion device, may be placed in the pyloric sphincter to inhibit or block the passage of material (fluid, chyme, etc.) from the stomach through the pylorus into the duodenum. The natural movements of the body (e.g., the gastrointestinal system) and the constant flow of material against the occluding device pose various challenges to preventing migration of a deployed occluding device. The peristaltic motion of the pylorus that passes material therethrough (e.g., distally into the small intestine), the generally less frequent reverse peristalsis through the pylorus (proximally into the stomach), and the natural tendency of the pylorus to expel material therethrough pose particular challenges to the placement and retention of pyloric occlusion devices. Back pressure from the large and small intestines via the duodenum may also cause device migration. Therefore, improved devices, systems, and methods for occluding the flow of material in the body while also preventing migration of the occlusion device relative to its deployment site are highly desired. Summary of the invention
[0004] The summary of the present disclosure is given to aid understanding, and those skilled in the art will understand that the aspects and features of the present disclosure can each be advantageously used alone in certain circumstances, or in combination with other aspects and features of the present disclosure in other circumstances. The inclusion or non-inclusion of elements and components in this summary is not intended to limit the scope of the object claimed for protection.
[0005] According to various principles of the present disclosure, an occluding device has a first end, a second end, and an intermediate region between the first end and the second end, and defines a lumen therethrough; a first retaining member extending radially outward along the first end of the occluding device; a second retaining member extending radially outward along the second end of the occluding device; a saddle along the intermediate region of the occluding device; and an occluding element positioned along at least a portion of the saddle to occlude the flow of material through the lumen; wherein the occluding element is formed of a coating material.
[0006] In some embodiments, at least one of the viscosity, percent solids, thickness, hardness, or flexibility of the coating material is selected to allow the coating material to block at least a portion of the lumen passing through the occluding device. In some embodiments, the coating material fills the portion of the lumen to define an inner diameter of less than 2 mm through the portion of the lumen. In some embodiments, the coating material extends along the saddle only about 2 to 3 mm. In some embodiments, the coating material is confined to a central region of the saddle, and the surrounding region of the saddle is not coated to promote tissue ingrowth.
[0007] In some embodiments, at least one of the viscosity, solids percentage, thickness, hardness, or flexibility of the coating material is selected to allow the coating material to inhibit expansion of at least a portion of the saddle, thereby occluding the flow of material through a lumen defined through the occluding device.
[0008] In some embodiments, at least one of the first retaining member or the second retaining member has an outer diameter that is at least about ten times greater than an outer diameter of the saddle.
[0009] In some embodiments, the first retention member and the second retention member have surfaces facing the saddle portion configured to promote tissue ingrowth therein.
[0010] According to various principles of the present disclosure, a method of occluding a lumen of an occluding device includes: narrowing a middle region of a tubular element to define a saddle; forming a first retaining member along a first end of the tubular element, the first retaining member having an outer diameter greater than an outer diameter of the saddle; forming a second retaining member along a second end of the tubular element, the second retaining member having an outer diameter greater than an outer diameter of the saddle; and applying a coating material to a portion of the saddle region to occlude the portion of the lumen of the occluding device extending therein.
[0011] In some aspects, the method further comprises restricting a portion of the saddle such that a diameter of the lumen within the restricted portion of the saddle is 6 mm or less.
[0012] In some aspects, applying the coating further comprises applying a coating material having at least one of a viscosity, solid percentage, thickness, hardness, or flexibility, which allows the coating material to block at least a portion of the lumen passing through the occluding device and / or inhibit expansion of the coated portion of the saddle, thereby occluding the flow of a substance through the lumen defined as passing through the occluding device.
[0013] In some aspects, the method further includes leaving a portion of the saddle and surfaces of the first and second retention members that face the saddle uncoated to promote tissue ingrowth therein.
[0014] According to various principles of the present disclosure, an occluding device has a first end, a second end, and an intermediate region between the first end and the second end, and defines a lumen therethrough; a first retaining member extending radially outward along the first end of the occluding device; a second retaining member extending radially outward along the second end of the occluding device; a saddle along the intermediate region of the occluding device; an occluding element positioned along at least a portion of the saddle to occlude the flow of material through the lumen; wherein the diameter of at least a portion of the lumen extending through the saddle is less than about 6 mm.
[0015] In some embodiments, the occlusive element is formed of a coating material applied to the saddle. In some embodiments, the occlusive element is positioned around a portion of the exterior of the saddle to inhibit expansion of the saddle. In some embodiments, the occlusive element extends within a portion of the lumen extending through the saddle to form a plug within a portion of the lumen extending through the saddle. In some embodiments, the coating material is confined to a central region of the saddle, and the surrounding region of the saddle is not coated to promote tissue ingrowth. In some embodiments, the surfaces of the first retaining member and the second retaining member that face the saddle are not coated to promote tissue ingrowth therein.
[0016] In some embodiments, at least one of the first retaining member or the second retaining member has an outer diameter that is at least about ten times greater than an outer diameter of the saddle.
[0017] In some embodiments, at least a portion of the lumen extending through the saddle has a diameter of about 2 mm.
[0018] According to various principles of the present disclosure, a method for occluding a body passage includes deploying an occluding device in the body passage, the occluding device defining a lumen therethrough and having a saddle region, a first retaining member extending outward along a first end of the occluding device, and a second retaining member extending outward along a second end of the occluding device; wherein: an occluding element is provided along a portion of the saddle to occlude a portion of the lumen of the occluding device therein, and the remaining portion of the saddle not occluded by the occluding element is not coated to promote tissue ingrowth therein.
[0019] In some aspects, the occlusive element is a coating that occludes a portion of the lumen of the occlusive device that is within the portion of the saddle along which the occlusive element is disposed.
[0020] In some aspects, the occlusive element prevents expansion of the portion of the saddle along which the occlusive element is disposed.
[0021] In some aspects, surfaces of the first retention member and the second retention member configured to fit against tissue are configured to promote tissue ingrowth therein.
[0022] In some aspects, the inner diameter of at least a portion of the saddle along which the occlusive element is disposed is 6 mm or less.
[0023] Embodiments of devices formed according to various principles of the present disclosure may include one or more of the following features individually and independently or in any appropriate combination: The device may include an occlusive element that blocks and / or is configured to prevent a portion of the lumen of the occlusive device from expanding within a portion of the saddle along which the occlusive element is disposed. The inner diameter of at least a portion of the saddle along which the occlusive element is disposed may be 6 mm or less. The occlusive element may extend within a portion of the lumen extending through the saddle. The occlusive element may be positioned around a portion of the exterior of the saddle to inhibit expansion of the saddle. The occlusive element may be formed by a coating material applied to the saddle. The coating material may fill the portion of the lumen to define an inner diameter of the portion passing through the lumen of less than 2 mm. The coating material may extend along the saddle by only about 2 to 3 mm. The coating material may be limited to a central region of the saddle, and the surrounding region of the saddle is not coated to promote tissue ingrowth. At least one of the viscosity, solid percentage, thickness, hardness, or flexibility of the coating material may be selected to allow the coating material to block at least a portion of the lumen passing through the occlusive device. At least one of the viscosity, solid percentage, thickness, hardness, or flexibility of the coating material may be selected to allow the coating material to inhibit expansion of at least a portion of the saddle, thereby occluding the flow of material through the lumen defined as passing through the occluding device. The outer diameter of at least one of the first retaining member or the second retaining member may be at least about ten times greater than the outer diameter of the saddle. The first retaining member and the second retaining member may have a surface facing the saddle, the surface being configured to promote tissue ingrowth therein. The surfaces of the first retaining member and the second retaining member facing the saddle may be configured to promote tissue ingrowth therein. The diameter of at least a portion of the lumen passing through the saddle may be about 2 mm. The device may be formed by restricting a portion of the saddle, such that the diameter of the lumen within the restricted portion of the saddle is 6 mm or less. The device may be formed by applying a coating material having at least one of a viscosity, solid percentage, thickness, hardness, or flexibility, allowing the coating material to block at least a portion of the lumen passing through the occluding device and / or inhibit expansion of the coated portion of the saddle, thereby occluding the flow of material through the lumen defined as passing through the occluding device. A portion of the saddle, and / or surfaces of the first and second retention members that face the saddle and are configured to fit against tissue may be configured to promote tissue ingrowth therein.
[0024] These and other features and advantages of the present disclosure will be apparent from the following detailed description, and the scope of the claimed invention is set forth in the appended claims. Although the following disclosure is presented in the form of aspects or embodiments, it should be understood that each aspect may be claimed separately or in combination with aspects and features of that embodiment or any other embodiment. BRIEF DESCRIPTION OF THE DRAWINGS
[0025] Non-limiting embodiments of the present disclosure will be described in an exemplary manner with reference to the accompanying drawings, which are schematic and not intended to be drawn to scale. The accompanying drawings are for illustrative purposes only, and the dimensions, positions, orders, and relative sizes reflected in the figures in the accompanying drawings may vary. For example, the device may be enlarged so that details can be discerned, but the device is intentionally scaled down in relation to, for example, matching in a delivery catheter or working channel of an endoscope. In the accompanying drawings, identical or nearly identical or equivalent elements are generally represented by the same reference symbols, while similar elements are generally represented by similar reference symbols, distinguished by increments of 100, and redundant descriptions are omitted. For the sake of clarity and simplicity, not every element is marked in each drawing, nor is every element of each embodiment shown, because these illustrations are not necessary for those skilled in the art to understand the present disclosure.
[0026] The detailed description will be better understood in conjunction with the accompanying drawings, in which like reference characters represent like elements, as follows:
[0027] Figure 1 A perspective view of an embodiment of an occlusive device formed in accordance with aspects of the present disclosure and positioned in a schematic diagram of a gastrointestinal environment is shown.
[0028] Figure 2 An elevation view is shown of an example of an implementation of an occluder device formed according to various principles of the present disclosure.
[0029] Figure 3 An elevation view is shown of another example of an implementation of an occluder device formed according to various principles of the present disclosure.
[0030] Figure 4 An elevation view is shown of another example of an implementation of an occluder device formed according to various principles of the present disclosure.
[0031] Figure 5 A schematic elevation view is shown of another example of an implementation of an occluder device formed according to various principles of the present disclosure. DETAILED DESCRIPTION
[0032] The following detailed description should be read with reference to the drawings depicting illustrative embodiments. It should be understood that the present disclosure is not limited to the specific embodiments described, as they may vary. All devices, systems and methods discussed herein are examples of devices and / or systems and / or methods implemented according to one or more principles of the present disclosure. The examples of each embodiment are provided in an explanatory manner, and are not the only way to implement these principles, but are only examples. Therefore, references to elements or structures or features in the drawings must be understood as references to examples of embodiments of the present disclosure, and should not be understood as limiting the present disclosure to the specific elements, structures or features shown. A person of ordinary skill in the art will think of other examples of ways to implement the disclosed principles after reading the present disclosure. In fact, it will be clear to those skilled in the art that various modifications and changes may be made to the present disclosure without departing from the scope or spirit of the present subject matter. For example, a feature shown or described as part of an embodiment may be used together with another embodiment to produce a further embodiment. Therefore, this goal is intended to cover modifications and changes within the scope of the appended claims and their equivalents.
[0033] It should be understood that the present application sets forth the present disclosure in various levels of detail. In some cases, details that are not necessary for a person of ordinary skill in the art to understand the present disclosure, or details that would make other details difficult to understand, may be omitted. The terms used herein are only used to describe specific embodiments and are not intended to limit the scope of the appended claims. Unless otherwise defined, the technical terms used herein should be understood as terms commonly understood by a person of ordinary skill in the art to which the present disclosure belongs. According to the present disclosure, all devices and / or methods disclosed and claimed herein can be manufactured and performed without undue experimentation.
[0034] As used herein, "proximal" refers to the direction or position closest to a user (a medical professional or clinician or technician or operator or physician, etc., such terms are used interchangeably herein without limitation, and include automatic controller systems or others), such as when the device is used (e.g., the device is introduced into the patient's body, or during implantation, positioning or delivery), and / or when closest to a delivery device, and "distal" refers to the direction or position farthest from the user, such as when the device is used (e.g., the device is introduced into the patient's body, or during implantation, positioning or delivery), and / or when closest to a delivery device. "Longitudinal" refers to extending along the longer or larger dimension of an element. "Center" refers to at least approximately bisecting the center point and / or being approximately equidistant from the periphery or border, while "central axis" refers to a line that at least approximately bisects the center point of the opening relative to the opening, extending longitudinally along the length of the opening when the opening includes, for example, a tubular element, a channel, a cavity or an orifice. As used herein, a channel or a lumen is not limited to a circular cross-section. As used herein, the "free end" of an element is the end beyond which the element does not extend.
[0035] According to various principles of the present disclosure, the implantable device is configured to occlude (understood herein as including complete or substantially complete or even partial occlusion, unless otherwise specified) the flow of substances through the anatomical deployment site. As used herein, the deployment site of the device is the site or position where the device is deployed, positioned, implanted, extended, placed, etc. in the human body (such terms are used interchangeably herein, but are not intended to be limiting), and may also be the intended treatment site or position once the device is deployed and used. The deployment site may be a body passage or lumen, such terms are used interchangeably herein, but are not intended to be limiting, and the broad principles of the present disclosure are applicable to body passages, lumens, cavities, etc., or other anatomical structures of various shapes and sizes. A body passage may extend between anatomical structures (e.g., a body cavity or organ adjacent to a body passage), and its diameter is generally larger than the body passage.
[0036] The occluding device formed according to various principles of the present disclosure can be deployed as a saddle area of the occluding device extending across the body passage, through the body passage, in the body passage, etc. (such terms are used interchangeably herein without intention to limit). The body passage may have an entrance and an exit, and the implantable device may be provided with a retaining member (which may alternatively be referred to as a flange), which is installed as an anti-migration structure relative to the anatomical structure (e.g., body wall) along or adjacent to the entrance and / or exit of the body passage, which is configured to resist the migration of the implantable device from the deployment site (e.g., relative to the body passage). It should be understood that terms such as resist, inhibit, prevent (and other grammatical forms thereof) can be used interchangeably herein, but are not intended to be limited. The retaining member can extend radially outward from either end of the middle region (along the one where the saddle is positioned). It should be understood that, unless otherwise specified, terms such as along the end or located at the end or on the end or adjacent to the end can be used interchangeably herein without intention to limit, and are intended to indicate a general relative spatial relationship, rather than a precisely limited position. The retaining member is configured to engage one or more anatomical structures at the deployment site to inhibit the movement of the occluding device relative to the deployment site. For example, the retaining member can be in the form of a lateral extension or flange that is wider than the middle region of the device and wider than the body passage in which the middle region of the device is deployed. The retaining member is wider than the saddle (in a radial direction transverse to the longitudinal axis of the body passage) and is configured to fit against a body wall extending radially outward from the body passage.
[0037] In some embodiments, at least one retaining member is configured to resist movement of the implantable device relative to the deployment site. In some embodiments, the first retaining member and the second retaining member are similar in shape, such as having a curved surface, which is oriented to resist movement of the retaining member, although these shapes may not have the same size (i.e., the shapes may have different relative sizes, scales or proportions). For example, the first retaining member and the second retaining member may be essentially replicas of each other (optionally with different relative proportions) and are oriented in substantially the same direction. Alternatively, in some embodiments, the first retaining member and the second retaining member may be mirror images (e.g., similar shapes facing substantially opposite directions, optionally with different relative proportions). In some embodiments, the first retaining member and the second retaining member are generally not the same or asymmetric. For example, the first retaining member and the second retaining member may have different shapes, sizes, relative proportions, etc. In some embodiments, a coating is applied to a portion of at least one retaining member to strengthen and / or reduce the flexibility of the retaining member to increase its pull-out strength. In some embodiments, at least a portion of the surface of at least one retaining member in contact with the tissue at the deployment site is configured (e.g., not coated with a material that can inhibit tissue ingrowth) to promote tissue ingrowth relative to it. It should be understood that the coating may be applied to the outwardly facing surface of the retaining member, which faces away from the saddle and is not in contact with the tissue, while at least a portion of the inwardly facing surface of the retaining member in contact with the tissue is configured to promote tissue ingrowth relative to it. In some embodiments, at least one retaining member is formed with a double wall (two walls adjacent and in contact with each other or spaced apart), each wall forming a side of the retaining member. The wall of the double-walled retaining member that is close to the saddle (and typically contacts the tissue at the deployment site) can be considered to be the inner side of the retaining member, while the wall of the double-walled retaining member that is away from the saddle (and typically does not contact the tissue) can be referred to as the outer side of the retaining member in this article. In some embodiments, more than one retaining member extends along one or both ends of the occluding device.
[0038] In some embodiments, the first retaining member and the second retaining member are generally not identical or symmetrical. For example, the first retaining member and the second retaining member may have different shapes, sizes, relative proportions, etc. In some embodiments, the occluding device positioned across the pylorus may have an enlarged stomach retaining member (e.g., having a diameter greater than the duodenal retaining member) to resist distal migration from the stomach to the duodenum. In some embodiments, the occluding device positioned across the pylorus may have an elongated duodenal retaining member that extends from the saddle further than the stomach retaining member to extend into the duodenum to enhance retention therein.
[0039] According to one aspect of the present disclosure, an implantable device may be particularly configured to occlude the flow of a substance through an anatomical structure. Terms such as occlusion, blocking, preventing, inhibiting, hindering, reducing, delaying, etc. (and their various variations) are used interchangeably herein, but are not limited to indicating that the flow of a substance is reduced by more than 50% and up to 100%, including increments of about 1% therebetween. In certain deployment sites, complete occlusion may not be achieved due to a variety of flow patterns through the channel or other anatomical features of the body channel. For example, in an embodiment in which the occluding device is configured to be deployed across the pylorus, considerable fluid flow pressure may be applied to the gastric side of the device, and / or considerable back pressure may be applied to the duodenal side of the device. Therefore, a small lumen may be retained by the occluding device, for example, sufficient to allow gas or low-viscosity fluid to pass through, without causing excessive pressure on the occluding device that may cause the occluding device to migrate.
[0040] According to various principles of the present disclosure, an occluding element is configured to occlude at least a portion of a lumen defined as passing through the occluding device, and the occluding element is positioned on at least a portion of a middle region of the occluding device in a manner that inhibits or prevents material from flowing through the lumen through which it passes. The occluding element may be a separately formed element applied to the saddle (e.g., within a lumen passing through the saddle, and / or on at least a portion of the exterior of the saddle), or may be a further deformation of the saddle (e.g., curling). For convenience, and not intended to be limiting, the occluding elements referred to herein are applicable to occluding elements that are separately formed and applied to the exterior of the occluding device and / or within the occluding device, as well as further deformations of the saddle, which extend beyond the narrowing of the middle region to distinguish the saddle from the retaining member at the end of the occluding device.
[0041] In some embodiments, the occluding element is a coating of a plugging material that is applied to at least a portion of the saddle of the occluding device to form an obstructing material. In some embodiments, the viscosity and / or solid percentage of the coating material is selected to achieve the desired occlusion. Additionally or alternatively, the thickness of the coating material applied to at least a portion of the saddle region can achieve the desired occlusion. In some embodiments, the properties of the coating material (e.g., extensibility, thickness, etc.) inhibit the expansion of the saddle region of the occluding device to inhibit or prevent solid or semi-solid substances from flowing therethrough. In some embodiments, the coating material forms a plug that occludes a passage through the occluding device along at least a portion of the middle region of the occluding device. Additionally or alternatively, the coating material may form a restriction relative to the saddle that limits the expansion of the saddle region of the expandable occluding device, thereby blocking the passage of occlusive substances through the lumen of the occluding device. In some embodiments, the occlusive device is formed of a plurality of filaments or the like that are braided, woven, interlaced, knitted, wound, plaited, looped (e.g., bobbinet-style), knotted, etc. (such terms are used interchangeably herein without limitation), or laser cut tubes (which in some cases may be considered to form a plurality of struts), or are otherwise formed to facilitate such ability to transform configurations. It should be understood that the term filament is used for convenience and is used interchangeably herein with terms such as wire or strand or fiber or strut without limitation. Such formation of the wall of the device may leave a plurality of openings passing therethrough, such as between the filaments. It should be understood that the term opening is used for convenience and is used interchangeably herein with terms such as space or gap without limitation. A coating may be applied to the device, such as extending through gaps in the wall of the device, to prevent material from flowing through these gaps and forming an occlusive element. Such coatings may be similar to coatings known in the art for use with occluding devices to occlude flow through the wall of the device and / or inhibit tissue ingrowth into or relative to the wall of the occluding device. It should be understood that, in accordance with various principles of the present disclosure, such coatings are typically lower in viscosity and / or have a lower solids percentage and / or are applied in less amount than, for example, materials used to occlude the flow of material through the lumen of the occluding device by forming a plug therein.
[0042] In some embodiments, additional structures such as curling (e.g., deformation of the saddle region or addition of a constriction element around the saddle region) may be provided along at least a portion of the saddle region of the occluding device to enhance occlusion of material passing through the lumen of the occluding device, or additional occluding elements (e.g., dowels, pins, rods, mandrels, etc.) may be inserted into the lumen of the occluding device. Such additional structures may occlude at least a portion of the narrow middle region of the occluding device.
[0043] To facilitate delivery and deployment and optionally endoscopic or transluminal removal (or otherwise without requiring open surgery), devices formed according to the various principles of the present disclosure can be configured to transition or move between a folded or compact delivery configuration and an expanded deployment configuration. The device can be made of a biocompatible material (e.g., a metal or polymer or alloy), such as a shape memory or thermoformable material (e.g., a nickel-titanium alloy such as Nitinol, or a cobalt-chromium-nickel-molybdenum alloy such as ) which can be advantageously used to facilitate expansion of the device into a desired deployment configuration.
[0044] Various embodiments of the occlusive device formed according to various principles of the present disclosure will now be described with reference to the examples shown in the accompanying drawings. References to "one embodiment", "embodiment", "some embodiments", "other embodiments", etc. in this specification refer to one or more specific features, structures and / or characteristics according to the principles of the present disclosure and can be used in combination with the embodiment. However, such references do not necessarily mean that all embodiments include specific features, structures and / or characteristics, or that the embodiment includes all features, structures and / or characteristics. Some embodiments may include one or more such features, structures and / or characteristics, and various combinations thereof. In addition, references to "one embodiment", "embodiment", "some embodiments", "other embodiments", etc. in various places in the specification do not necessarily all mean the same embodiment, and separate or alternative embodiments are not necessarily mutually exclusive with other embodiments. When describing specific features, structures and / or characteristics in conjunction with an embodiment, it should be understood that these features, structures and / or characteristics may also be used in conjunction with other embodiments, whether or not explicitly described, unless otherwise explicitly stated. It should also be understood that because it would be cumbersome to describe all of the numerous possible combinations and sub-combinations of features, structures, and / or characteristics, these features, structures, and / or characteristics may be used or presented alone, or combined with each other in various combinations to create alternative embodiments that are considered part of the present disclosure. In addition, various features, structures, and / or characteristics are described that may be exhibited by certain embodiments but not by other embodiments. Similarly, various features, structures, and / or characteristics or requirements are described that may be features, structures, and / or characteristics or requirements of certain embodiments but may not be features, structures, and / or characteristics or requirements of other embodiments. Accordingly, the present disclosure is not limited to only the embodiments specifically described herein, and the examples of embodiments disclosed herein are not intended to limit the broader aspects of the present disclosure.
[0045] It should be understood that the common features in each figure are identified by a common reference element, and for the sake of brevity and convenience and not intended to be limiting, the description of the common features is generally not repeated. For the sake of clarity, not all parts with the same reference symbol are numbered. It should be understood that in the description below, similar elements or parts with reference symbols greater than 100 in each illustrated embodiment are generally represented by the same reference symbol increased by a multiple of 100, and redundant descriptions are generally omitted for the sake of brevity. In addition, specific features in one embodiment may be used across different embodiments, and when appearing in different embodiments, they may not be individually labeled or described in detail, but with reference to the previous description of similar elements.
[0046] Turning now to the accompanying drawings, Figure 1 An example of an implantable device 100 is shown, which for convenience and not intended to be limiting is referred to herein as an occlusion device 100, and which is formed according to various principles of the present disclosure and is Figure 1 . The illustrated occluding device 100 has a proximal end 101, a distal end 103, and a middle region 105 therebetween. A proximal retaining member 110 is disposed along the proximal end 101 of the occluding device 100, a distal retaining member 120 is disposed along the distal end 103 of the occluding device 100, and a saddle 130 extends between the proximal end 101 and the distal end 103 and along the middle region 105. The saddle 130 may be configured to be positioned to pass through a body passage. The retaining members 110, 120 are wider than the saddle 130 and are positioned to abut against (e.g., extend outwardly from) respective body walls around respective entrances and exits of the body passage to prevent migration of the occluding device 100 relative to the body passage (distal / proximal or downstream / upstream of a typical flow direction of material through the body passage). In the example of the illustrated embodiment, the saddle 130 is located within the pylorus P, the proximal retaining member 110 is positioned within the stomach S (e.g., against the gastric antrum) and is configured to inhibit the occlusion device 100 from migrating distally into the duodenum D, and the distal retaining member 120 is positioned within the duodenum D and is configured to inhibit the occlusion device 100 from migrating proximally into the stomach S.
[0047] Figure 2An example of an embodiment of an occluding device 200 formed according to various principles of the present disclosure is shown having a first (e.g., proximal) retention member 214 along a first (e.g., proximal) end 201 thereof, a second (e.g., distal) retention member 216 along a second (e.g., distal) end 203 thereof, and a saddle 230 along a mid-region thereof that narrows so that the diameter of the lumen 207 of the occluding device within this portion of the saddle 230 can be minimized to near zero (e.g., completely closed) to occlude the lumen 207 passing through the occluding device 200. It should be understood that it may be desirable to allow a small amount of material (e.g., gas or liquid) to pass through the lumen 207 so that pressure acting on the occluding device 200 (e.g., back pressure from the duodenum D or pressure from gastric material in the stomach S) does not move the occluding device 200 or cause the occluding device 200 to migrate. For example, the narrowest portion of the lumen 207 through the occluding device 200 may have a diameter of about 0 to 2 mm, such as 1 to 1.5 mm, including 0.01 mm increments therebetween. It should be understood that the inner diameter of the saddle 230 is generally not equal to zero, so that some movement of liquid or gas through the saddle 230 into the duodenum is acceptable.
[0048] The illustrated occluding device 200 may be formed of a plurality of filaments, for example, braided to form a tubular element. The material of the tubular element (e.g., the material of the filaments braided or woven to form the tubular element) may be a shape memory material, such as, but not limited to, a nickel-titanium alloy (e.g., Nitinol) or a cobalt-chromium-nickel-molybdenum alloy (e.g., ). The configuration of the occluding device 200 can be set by shaping the shaped tubular element, for example, by compressing or restricting or constricting or clamping or otherwise narrowing the middle region 205 (for example, using a mold form, also referred to as an intermediate form) to form a saddle 230, and optionally expanding the end regions to form retaining members 210, 220. According to various principles of the present disclosure, the ends of the tubular element forming the occluding device can be maintained (for example, locked to prevent sliding or rotation) while using a tool to form the shape of the occluding device. Therefore, it can be understood that the occluding device formed with at least a portion of the saddle is narrower than the saddle of previous occluding devices, which allows the occluding device to be formed using tools similar to those currently used to form occluding devices with saddles without further manipulation of the tubular element, such as twisting, to narrow the saddle. The material of the occluding device 200 thus formed can be treated (for example, heated) in a manner known to those skilled in the art to set the formed tubular element to the desired shape, the details of which do not form part of the present disclosure.
[0049] According to various principles of the present disclosure, at least a portion of the middle region 205 of the occluding device 200 is further narrowed to reduce the portion of the saddle 230 through which the lumen 207 of the occluding device extends, thereby occluding the flow of material through the narrowed portion of the saddle 230 and the lumen 207 by applying an occluding element 240 thereto.
[0050] In some embodiments, the portion of the lumen 207 extending through the further narrowed portion of the saddle 230 is further narrowed or occluded by applying a coating material thereon to form an occlusive element 240. The occlusive element 240 formed of the coating material can occlude or otherwise block a portion of the lumen 207 within the narrowed portion of the saddle 230. Additionally or alternatively, the coating material can resist expansion of the saddle 230 (e.g., support inherent expansion resistance), thereby limiting the passage of material through the saddle 230. The coating material can be formed of a biocompatible polymer material, such as silicone, urethane, polyurethane, urethane polyether block amides (PEBA), polyethylene, polyethylene terephthalate (PET), polyvinylidene difluoride (PVDF), polytetrafluoroethylene (PTFE), expanded polytetrafluoroethylene (ePTFE), polyester, polypropylene, polynaphthalene, Thermoplastic elastomers, SEBS and SBS polymers, or similar biocompatible polymer formulations and / or copolymers thereof and / or combinations thereof.
[0051] The coating material can be applied in a manner to increase the volume of the coating so that the coating occludes the saddle 230 by plugging the saddle 230 and / or by preventing the saddle 230 from expanding. For example, the coating thickness on the wall of the saddle 230 can be at least about 100 μm, and even as thick as about 500 μm, including increments of 1 μm therebetween. In some embodiments, while about 0.1 g of coating material is applied to coat an occlusive device of the prior art (e.g., to prevent material from passing through its wall), up to about 0.3 g or even up to about 0.4 g of coating material can be applied to the occlusive device 200 to form an occlusive element 240 according to various principles of the present disclosure. In some embodiments, one or more material properties of the coating allow the coating to form an occlusive element 240 (e.g., a plug or other form of obstruction) rather than a simple coating (e.g., a simple covering layer). More specifically, one or more properties of the coating material facilitate occlusion by narrowing the middle region 205 of the occluding device 200, as compared to typical coating materials used on prior art stents (e.g., inhibiting tissue ingrowth, and / or preventing material from passing through the stent wall, and / or imparting structural rigidity / reducing flexibility, and / or imparting a degree of lubricity to facilitate movement relative to tissue or prevent tissue abrasion). In some embodiments, the viscosity of the coating material is higher than prior art coatings used for the above purposes, so that the coating can not only simply coat the wall of the occluding device 200, but can also form a mass (e.g., a plug) within the portion of the lumen 207 of the occluding device within the saddle 230 to occlude the saddle 230. The additional viscosity can also allow the coating to form an occluding element 240 within or around the saddle 230 to limit the expansion of the saddle 230 and thereby inhibit or prevent the passage of material therethrough. Additionally or alternatively, in some embodiments, the coating material is a higher solids percentage material (having a higher solids percentage) than prior art coating materials, such that the coating material of the present disclosure may form a mass within the portion of the lumen 207 of the occlusion device within the saddle 230 to occlude the saddle 230 and / or form a restriction element relative to the saddle 230 to restrict expansion of the saddle 230, thereby inhibiting or preventing the passage of substances therethrough. Additionally or alternatively, in some embodiments, a sufficient thickness of the coating material may be applied to cause at least a portion of the lumen 207 extending through the saddle 230 to be occluded and / or restrict expansion of the saddle 230 and thereby inhibit or prevent the passage of substances therethrough. For example, while typical coatings for inhibiting tissue ingrowth, increasing lubricity, etc. may have a greater thickness of about 45 to 55 μm, a coating forming the occlusive element 240 according to various principles of the present disclosure may have a thickness of about 100 μm or greater, and may even have a thickness of about 500 μm, including 1 μm increments therebetween. Additionally or alternatively, in some embodiments, the coating material may have sufficient hardness to cause occlusion of the saddle 230 and / or limit expansion of the saddle 230 (to resist expansion of the saddle 230) to thereby prevent or inhibit passage of matter.For example, an increase in hardness can affect the solid percentage of the material, with the higher the solid percentage, the less the material will flow during the curing process, resulting in a thicker coating being applied. Additionally or alternatively, in some embodiments, the flexibility and / or elasticity of the coating material can be selected to cause at least a portion of the lumen 207 extending through the saddle 230 to be occluded and / or to restrict the expansion of the saddle 230, thereby inhibiting or preventing the passage of matter therethrough. For example, the saddle 230 can be coated in such a manner as to prevent the lumen from expanding by more than about 2 to 5 mm and / or to allow the outer diameter of the saddle to increase by no more than 75%. It should be understood that one or more of such characteristics of the coating material and / or other characteristics not listed herein can help the coating material occlude (e.g., plug) and / or restrict the saddle 230, such as by being integrated into the saddle 230 or simply by being formed around the periphery of the saddle 230 to resist the expansion of the saddle 230. As described above, in some embodiments, it may be desirable to leave a lumen with a smaller diameter (e.g., 0.1 to 0.6 mm). In such embodiments, a very narrow mandrel or guidewire may be inserted into the lumen 207 of the occluding device 200 prior to applying the coating to a portion of the saddle 230 to leave a minimum inner diameter in a portion of the saddle 230, as described above.
[0052] In some embodiments, the additional narrowing of the saddle 230 and the coating material can achieve the desired occlusion without other mechanical deformation or other manipulation of the saddle 230, such as twisting the saddle 230. Typically, the occluding device 200 is constrained or otherwise placed in a reduced diameter configuration to allow intraluminal delivery through the body (e.g., for transcatheter delivery without invasive open surgery). Once the occluding device 200 is deployed, the occluding device 200 can be transformed from a delivery configuration (a constricted, constricted, reduced diameter, etc. configuration) to a deployed (expanded) configuration, while the occluding portion of the saddle 230 generally remains in the occluding configuration. For example, after the occluding device 200 is deployed, the coated portion of the saddle 230 may not be transformed into a configuration that is significantly different from its delivery configuration. For example, the inner diameter of the saddle 230 may not expand more than about 2 to 5 mm and / or the outer diameter of the saddle 230 may not increase more than about 75%.
[0053] According to various principles of the present disclosure, the inner diameter of the portion of lumen 207 within the further narrowed portion of saddle 230 (formed to be narrower than a typical saddle of a prior art occluding device) may be 6 mm or less, and preferably less than about 5 mm or less, and even as small as about 2 mm, or as small as about 1.5 mm, or even as small as about 1 mm ± 0.2 mm, with increments of about 0.1 mm included between these measurements. The outer diameter of this portion of saddle 230 may be less than about 7 mm or less, and preferably less than about 6 mm or less, and as small as about 2 mm, and even as small as about 2 mm ± 0.2 mm, with increments of about 0.1 mm included between these measurements. The diameter of the filament (e.g., metal wire) forming occluding device 200 may be about 0.005 inches (0.127 mm), or even up to about 0.010 inches (0.254 mm). It should be understood that, as described herein, "occlusion" of a portion of the lumen 207 through the saddle 230 does not require complete occlusion, but may allow some fluid (gas and / or liquid) to pass through that may otherwise cause sufficient pressure on the occluding device 200 to cause the occluding device 200 to migrate or otherwise move the occluding device 200 from its deployment site, such as by allowing a lumen with a minimum diameter to extend through the occluding device 200, as described above. For example, an occluding element 240 formed of a coating material may extend a portion of the lumen 207 through the saddle 230, the inner diameter of which is less than about 2 mm but greater than 0, including increments of about 0.1 mm.
[0054] The coating material used to form the occlusive element 240 according to various principles of the present disclosure generally inhibits tissue ingrowth into the underlying structure. It should be understood that the coating material forming the occlusive element 240 need not be applied along the entire length of the saddle 230 along the longitudinal axis LA of the occlusive device 200, thereby allowing (and possibly promoting) at least some tissue ingrowth along the length of the saddle 230 without the need for such coating material. It is believed that tissue ingrowth relative to the occlusive device 200 enhances the retention of the occlusive device 200 relative to the body passage in which the occlusive device 200 is deployed, reducing and possibly preventing the migration of the occlusive device 200 from its deployment site. The coating material may be limited to applying a few millimeters along the length of the saddle 230. For example, in some embodiments, the size of the saddle 230 of the occlusive device 200 configured to be positioned across the pylorus P may correspond to the average length of the pylorus P, which is about 17 mm long. According to various principles of the present disclosure, the coating material may be applied only about 2 to 3 mm along the length of the saddle 230. In some embodiments, the coating material is confined to a substantially central location along the length of the saddle 230 .
[0055] To further enhance the benefit of tissue ingrowth relative to the occlusive device 200, the inwardly facing sides 212, 222 of the retention members 210, 220, respectively, are configured (eg, are uncoated) to promote tissue ingrowth. Figure 2 In the example of an embodiment of the occluding device 200 shown, the retaining members 210, 220 are double-walled retaining members, whereby the inwardly facing sides 212, 222 of the retaining members 210, 220 are the inner walls of the double-walled retaining members 210, 220, and the outwardly facing sides 214, 224 of the retaining members 210, 220 are the outer walls of the double-walled retaining members 210, 220. The retaining members 210, 220 are typically positioned against tissue surrounding the entrance / exit of the passageway in which the occluding device 200 is deployed (e.g., against the stomach S and duodenum D), and their diameters may be significantly greater than the diameter of the saddle 230 to increase the surface area of the occluding device 200 contacting the tissue. For example, the outer diameter of one or both of the retaining members 210, 220 may be at least about 10 times greater than the outer diameter of the saddle 230, and even up to about 20 times greater than the outer diameter of the saddle 230, including all multiples therebetween. This increase in the surface area of the tissue contacting side of the retaining members 210, 220 at the deployment site not only increases the pull-out strength of the retaining members 210, 220 (resistance to migration relative to the deployment site), but also provides a larger surface area for tissue ingrowth to increase the anti-migration effect of tissue ingrowth into the occluding device 200. In some embodiments, the outer diameter of the retaining members 210, 220 is at least about 30 mm or more, and can be as large as about 50 mm or even more, with an increase of about 0.5 mm included between such measurements. The retaining members 210, 220 can be formed from a tubular element, such as a braided tubular element, and the occluding device 200 is formed by constricting the middle region 205 to form the saddle 230 and / or by expanding the end regions of the tubular element (e.g., by inserting a gasket therein) to form the retaining members 210, 220. In some embodiments, the end rings are used to form extensions or lips 216, 226 extending axially from the retaining members 210, 220 in a direction away from the saddle 230.
[0056] In some embodiments, a coating can be applied to the portion of the occluding device 200 that is not in contact with the tissue to impart structural rigidity to achieve the purpose of anti-migration, as is well known in the art. The coating can include any suitable biocompatible material known in the art or previously known for this purpose, such as a polymeric material such as silicone, urethane, polyurethane, urethane polyether block amide (PEBA), polyethylene terephthalate (PET), polyvinylidene fluoride (PVDF), polytetrafluoroethylene (PTFE), expanded polytetrafluoroethylene (ePTFE), polyester, polypropylene, polynaphthalene, Thermoplastic elastomers, SEBS and SBS polymers, etc., or similar biocompatible polymer formulations and / or copolymers thereof and / or combinations thereof. The coating may be applied to at least a portion of the outer surface 214, 224 of the retaining members 210, 220 and / or the weld (along the ends 201, 203 of the occluding device 200, which may be welded if the occluding device 200 is formed of a braided or woven material) or the lip 216, 226 (the axial extension of the occluding device 200 outwardly from the outward side of the retaining members 210, 220 in a direction away from the saddle 230).
[0057] In some embodiments, the occluder device may be configured to have a more gradual transition from a narrow saddle portion to a wider retaining member, such as Figure 2 For example, in Figure 3 In the example of an embodiment of the occluder device 300 shown, the diameter of the saddle 330 transitions to the wider retaining members 310, 320 with a gradual increase in the outer diameter of the saddle 330. For example, the diameter of the saddle 330 can transition to the wider retaining members 310, 320 at a slope of approximately 35 to 40 degrees. Figure 3 As shown, the transition region T can be configured to allow the saddle 330 to better match the anatomical contours of the deployment site to increase the contact of the saddle 330 with the tissue and / or increase the surface area of the saddle 330 and thereby improve tissue ingrowth in the uncoated saddle 330. The saddle 330 can be formed using a forming tool having a rounded surface, such as Figure 3 As shown, to reduce fatigue of the material forming the occluding device 300. In some embodiments, the occluding element 340, as described above and in Figure 2 The occlusive element 240 of the occlusive device 200 shown in FIG. 2 is disposed in the central region C and does not extend into the transition region T. In some embodiments, the central region C may have a shorter length relative to the transition region T, and the transition region T is characterized by an increase in outer diameter per millimeter that is greater than any change in outer diameter along the central region C. For example, in some embodiments, the length of the transition region T is about 16 to 18 mm ± 1 mm (including 0.05 mm increments therebetween), while the length of the central region C is about 4 to 8 mm ± 1 mm (including 0.05 mm increments therebetween). In some embodiments, the transition region T remains uncoated.
[0058] As described above, the occlusive element can be formed in a variety of ways to achieve a desired occlusion utilizing at least one narrowed portion of the saddle portion of an occlusive device formed according to various principles of the present disclosure. Figure 4An example of a crimped occlusive element 440 is shown positioned on the saddle 430 of the illustrated example of an embodiment of the occlusive device 400. The occlusive element 440 may be a swaged formation, or a separately formed clamp or band, applied to the exterior of the saddle 430. The occlusive element 440 is formed to inhibit expansion of the saddle 430 to occlude the passage of material from the lumen 407 of the occlusive device extending through at least a portion of the saddle 430. An example of a separately formed occlusive element 540, such as a dowel, pin, rod, bar, mandrel, etc., may be formed in a manner similar to that of a dowel, pin, rod, bar, mandrel, etc. Figure 5 The saddle 530 is shown positioned within the illustrated embodiment of the occluding device 500 to occlude the flow of material through the saddle 530. Figure 4 and 5 Such occlusive elements as shown and Figure 2 and 3 The occlusive elements 240, 340 shown and described above allow the occlusive device to have an uncoated saddle portion, promoting tissue ingrowth therein while also occluding the flow of material therethrough.
[0059] In view of the fact that the occlusion device formed according to the various principles of the present disclosure has a narrow saddle, and its lumen is substantially or nearly occluded along at least a portion thereof (e.g., a central region), a typical delivery system may need to be modified. For example, various implantable devices (e.g., stents and previous occlusion devices) having a lumen passing therethrough can be delivered by a flexible tubular elongated member of a delivery / deployment system (which can in turn be advanced through a delivery sheath and / or an endoscope and / or a delivery catheter). The guide wire can be initially inserted into the body intracavitary to guide the delivery / deployment device to the deployment site, and the implantable device can be deployed at the desired position at the deployment site. The lumen of the implantable device and the flexible tubular elongated member that conveys the implantable device can pass through the guide wire to be guided by the guide wire. The occlusion device formed according to the various principles of the present disclosure may not have a lumen passing therethrough that is large enough (at least not large enough at the occluded portion) to allow the flexible tubular elongated member to be inserted therein. Therefore, the occlusion device formed according to the various principles of the present disclosure can be inserted directly over the guide wire to be guided to the desired position of the deployment site. A pusher known to those of ordinary skill in the art may be used to push the occluding device out of the delivery sheath, where the occluding device is delivered intraluminally through the body to the deployment site. It should be understood that the above disclosed aspects may be applied to other passages within the body to reduce flow through such passages. Although embodiments of the present disclosure may be described with specific reference to medical devices and systems and procedures for treating the gastrointestinal system, it should be understood that such medical devices and methods may be used to treat tissues of the abdominal cavity, digestive system, urinary tract, reproductive tract, respiratory system, cardiovascular system, circulatory system, etc.
[0060] The foregoing discussion has a wide range of applications and has been presented for the purpose of illustration and description, and is not intended to limit the present disclosure to the form disclosed herein. It should be understood that various additions, modifications and substitutions can be made to the embodiments disclosed herein without departing from the concept, spirit and scope of the present disclosure. Specifically, it should be clear to those skilled in the art that the principles of the present disclosure can be embodied in other forms, structures, arrangements, proportions and by utilizing other elements, materials and components without departing from its concept, spirit or scope or features. For example, in order to simplify the present disclosure, the various features of the present disclosure are grouped together into one or more aspects, embodiments or configurations. However, it should be understood that the various features of certain aspects, embodiments or configurations of the present disclosure can be combined in alternative aspects, embodiments or configurations. Although the present disclosure is presented in the form of an embodiment, it should be understood that in order to achieve at least some desired characteristics and / or benefits of this theme or such individual features, the various individual features of this target do not need to exist in full. Those skilled in the art will appreciate that the present disclosure may have many modifications or variations of the structure, arrangement, proportion, material, components, etc. used in the practice of the present disclosure, which are particularly suitable for specific environments and operating requirements without departing from the principles or spirit or scope of the present disclosure. For example, an element shown as being formed as a whole may be composed of multiple parts, or an element shown as multiple parts may be formed as a whole, the operation of the element may be reversed or otherwise changed, and the size or dimensions of the element may be changed. Similarly, although operations, actions, or procedures are described in a particular order, this does not mean that such a particular order is required, or that all operations, actions, or procedures must be performed to achieve the desired result. In addition, other embodiments also fall within the scope of the following claims. In some cases, the operations described in the claims can be performed in a different order and still achieve the desired result. Therefore, the embodiments currently disclosed should be regarded as illustrative and not restrictive in all respects, and the scope of the subject matter claimed for protection is indicated by the appended claims and is not limited to the specific embodiments or arrangements described above or described or illustrated herein. In view of the foregoing, various features of any embodiment may be used and claimed alone or in combination with features of that or any other embodiment, the scope of the subject matter being indicated by the appended claims and not limited to the foregoing description.
[0061] In the foregoing description and the subsequent claims, the following should be understood. The terms "at least one", "one or more" and "and / or" used herein are open expressions, which are both conjunctions and separation words in operation. The terms "one", "one", "the", "first", "second", etc. do not exclude plural numbers. For example, the term "one" or "one" entity used herein refers to one or more of these entities. Therefore, the terms "one" (or "one"), "one or more" and "at least one" are used interchangeably herein. All directional references (such as proximal, distal, upper, lower, upward, downward, left, right, lateral, longitudinal, front, rear, top, bottom, above, below, vertical, horizontal, radial, axial, clockwise, counterclockwise and / or the like) are only used for identification purposes to help readers understand the present disclosure, and / or for distinguishing the area of related elements, and do not limit related elements, particularly with respect to the position, orientation or use of the present disclosure. The references to connections (such as attachment, coupling, connection and engagement) should be widely interpreted, and unless otherwise specified, the relative motion between the intermediate members and elements between the element sets is included. Thus, connected references do not necessarily imply that two elements are directly connected and have a fixed relationship to each other. References to identifiers (eg, primary, secondary, first, second, third, fourth, etc.) are not intended to indicate importance or priority, but rather are used to distinguish one feature from another.
[0062] The following claims are hereby incorporated by reference into this detailed description, with each claim itself serving as a separate embodiment of the present disclosure. In the claims, the term "comprises / comprising" does not exclude the presence of other elements, parts, features, regions, wholes, steps, operations, etc. In addition, although individual features may be included in different claims, these features may be advantageously combined together, and the inclusion in different claims does not mean that the combination of features is not feasible and / or disadvantageous. In addition, singular references do not exclude the plural. The reference symbols in the claims are merely examples of clarification and should not be construed as limiting the scope of the claims in any way.
Claims
1. An occluding device having a first end, a second end, and an intermediate region between the first end and the second end and defining a lumen therethrough, the occluding device comprising: a first retaining member extending radially outwardly along the first end of the occluder device; a second retaining member extending radially outwardly along the second end of the occluding device; a saddle along said middle region of said occluding device; as well as an occlusive element positioned along at least a portion of the saddle to occlude the flow of material through the lumen; The occlusive element is formed from a coating material.
2. The occluding device of claim 1, wherein at least one of the viscosity, solid percentage, thickness, hardness, or flexibility of the coating material is selected to allow the coating material to block at least a portion of the lumen passing through the occluding device.
3. The occlusive device according to claim 1 or 2, wherein the coating material fills the portion of the lumen to define an inner diameter through the portion of the lumen of less than 2 mm.
4. The occlusive device according to any one of claims 1 to 3, wherein the coating material is confined to a central region of the saddle and a peripheral region of the saddle is uncoated to promote tissue ingrowth.
5. An occluding device according to any one of claims 1 to 4, wherein at least one of the viscosity, solid percentage, thickness, hardness or flexibility of the coating material is selected to allow the coating material to inhibit expansion of at least a portion of the saddle, thereby occluding the flow of material through the lumen defined as passing through the occluding device.
6. The occlusive device of any one of claims 1 to 5, wherein an outer diameter of at least one of the first retaining member or the second retaining member is at least about ten times greater than an outer diameter of the saddle.
7. The occlusive device according to any one of claims 1 to 6, wherein the first and second retaining members have surfaces facing the saddle, the surfaces being configured to promote tissue ingrowth therein.
8. A method for occluding a lumen of an occluding device, the method comprising: narrowing a middle region of the tubular element to define a saddle; forming a first retaining member along a first end of the tubular element, the first retaining member having an outer diameter greater than an outer diameter of the saddle; forming a second retaining member along a second end of the tubular element, the second retaining member having an outer diameter greater than an outer diameter of the saddle; and A coating material is applied to a portion of the saddle region to occlude the portion of the occluding device extending therein.
9. The method of claim 9, further comprising restricting a portion of the saddle such that a diameter of the lumen within the restricted portion of the saddle is 6 mm or less.
10. The method of claim 8 or 9, wherein applying a coating further comprises applying a coating material having at least one of a viscosity, solid percentage, thickness, hardness, or flexibility that allows the coating material to block at least a portion of the lumen passing through the occluding device and / or inhibit expansion of the coated portion of the saddle, thereby occluding the flow of material through the lumen defined as passing through the occluding device.
11. The method of any one of claims 8 to 10, further comprising configuring a portion of the saddle and surfaces of the first and second retaining members that face the saddle to promote tissue ingrowth therein.
12. An occluding device having a first end, a second end, and an intermediate region between the first end and the second end and defining a lumen therethrough, the occluding device comprising: a first retaining member extending radially outwardly along the first end of the occluder device; a second retaining member extending radially outwardly along the second end of the occluding device; a saddle along said middle region of said occluding device; as well as an occlusive element positioned along at least a portion of the saddle to occlude the flow of material through the lumen; Wherein at least a portion of the lumen extending through the saddle has a diameter of less than about 6 mm.
13. The occlusive device of claim 12, wherein the occlusive element is a coating material applied to the saddle.
14. The occlusive device of claim 12 or 13, wherein an outer diameter of at least one of the first retaining member or the second retaining member is at least about ten times greater than an outer diameter of the saddle.
15. The occlusive device of any one of claims 12 to 14, wherein at least a portion of the lumen extending through the saddle has a diameter of about 2 mm.
